Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wenzhou Yicheng Jingzhan Biotechnology
Wenzhou, Zhejiang, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Wenzhou Yicheng Jingzhan Biotechnology is a Chinese clinical-stage biotechnology company founded in 2024 and based in Zhejiang, China. The company focuses on developing innovative peptide-based therapeutics for inflammatory, autoimmune, and ophthalmic diseases. Its lead candidate, Epivotide (伊匹乌肽), is a first-in-class cell-penetrating peptide inhibitor targeting the p55PIK regulatory subunit of PI3K (encoded by PIK3R3). Epivotide is currently in Phase 2 clinical development for multiple indications, including neurotrophic keratitis, dry eye, and perennial allergic rhinitis.
- Therapeutic areas
- OphthalmologyDermatologyInfectious DiseasesImmunology
- Modalities
- PeptideBiologic
- Industry
- Biotech
02
Partnerships
Wuhan Yicheng BiotechnologyYicheng Kangtai (Xiamen) BiotechnologyShenzhen Yixin Kang Biotechnology
Beyond the preview
Go deeper on Wenzhou Yicheng Jingzhan Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wenzhou Yicheng Jingzhan Biotechnology.